Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Tortoise Capital Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of July 31, 2025, for TYG and TEAF
-
Trump Media Reports Second Quarter 2025 Results
-
CORRECTION – Sony Joins the AR Alliance to Advance the Future of Augmented Reality Wearable Devices
-
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the Second Quarter Ended June 30, 2025
-
Denarius Metals Announces Decision Not to Proceed with 50/50 Joint Venture with Quimbaya Gold
-
TWC Enterprises Limited Announces Second Quarter 2025 Results And Eligible Dividend
-
Opendoor Regains Compliance with Nasdaq Minimum Bid Price Requirement and Cancels Special Meeting of Stockholders
-
Dr. Sebi Day: Healing the Community in Brooklyn, Aug 6-10
-
Lumine Group Inc. Announces Results for the Three and Six Months Ended June 30, 2025
-
Highland Opportunities and Income Fund Announces the Regular Monthly Distribution
-
Full Truck Alliance Co. Ltd. Announces Changes to Its Freight Brokerage Service
-
NETGEAR® Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Notice of Data Security Incident
-
Goldgroup Retains VLP for Market-Making Services
-
D. Boral ARC Acquisition I Corp. Announces Closing of $250,000,000 Initial Public Offering
-
Uniti Completes Merger with Windstream
-
Enovix Shareholder Reminder: Early Warrant Expiration Price Condition
-
Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds
-
Sky Harbour to Report Its Second Quarter 2025 Financial Results and Host Webcast Investor Call on August 12th, 2025
-
AM Best Affirms Credit Ratings of Palms Insurance Company, Limited and Palms Specialty Insurance Company, Inc.
-
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
SmartVascular Dx™ Test Elevates Vascular Risk Detection in the Northeast & Partnership with MOMS
-
SmartVascular Dx™ Test Elevates Vascular Risk Detection in the Northeast & Partnership with MOMS
-
ThreeD Capital Inc. Completes Private Placement Financing
-
Supreme Critical Metals Inc. Provides Third Default Status Update
-
ABRDN INCOME CREDIT STRATEGIES FUND ANNOUNCES "AT-THE-MARKET" EQUITY OFFERING PROGRAM
-
Sanatana Announces Market Making Services Agreement with Independent Trading Group
-
Guggenheim Investments Announces August 2025 Closed-End Fund Distributions
-
Pacific Bay Warrant Extension Not Proceeding
-
Spyre Therapeutics Announces Grants of Inducement Awards
-
Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios as of July 31, 2025
-
SEC Creates Task Force to Tap Artificial Intelligence for Enhanced Innovation and Efficiency Across the Agency
-
420 with CNW — Pennsylvania Lawmakers Remain Divided as Marijuana Bill Discussions Continue
-
“Bogotá Accounts for 60% of Foreign Investment in Technology Entering Colombia”
-
SSP Innovations and 3-GIS Set Stage for Strategic Realignment
-
Atrium Mortgage Investment Corporation Announces August 2025 Dividend and Q2 2025 Investor Conference Call Details
-
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
-
SUMMIT HOTEL PROPERTIES DECLARES SECOND QUARTER 2025 DIVIDENDS
-
Radiance Technologies Appoints Jay E. Town as Chief Compliance Officer
-
Trazeetravel.com Awards Inaugural Joey Fecci Award for Culinary Excellence
-
PRESIDENT ANGELA SNYDER TO RETIRE FROM FULTON FINANCIAL CORPORATION
-
Sirona Biochem Update to Shareholders on Financial Status and Operations
-
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
DIH Holding US, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
-
WEBUY GLOBAL LTD Announces Closing of Follow-on Offering
-
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Toll Brothers to Webcast Its Third Quarter 2025 Earnings Conference Call Live on August 20, 2025 at 8:30 a.m. (ET)
-
Infinity Bancorp Announces Second Quarter 2025 Financial Results
